Research Updates - Health Professionals

01 December 2023

Please see below the latest developments from the world of healthcare Research and Innovation

• New hope for patients with angina as stents proved to be an alternative to pain medication The trial has shown patients experiencing chest pain from reduced blood flow to the heart may benefit from having a stent implanted instead of chest pain medication.
• Antibiotics make little difference to children’s chest infections Chest infections are one of the most common conditions seen in primary care with at least 2 in 5 children being prescribed antibiotics. New research has shown that antibiotics made little difference and findings could help reduce prescripons.
• Life-saving enzyme replacement therapy approved for rare genetic condition in babies Wolman disease occurs in one in every 350,000 births and affects one or two babies born every year in England. Babies with this rare genetic disorder do not produce an enzyme that is required to break down fats in the body. The National Institute for Health and Care excellence (NICE) has recommended the enzyme replacement therapy sebelipase alfa (Kanuma®) for use by the NHS for the treatment of Wolman disease.

 

If you want to get in touch about our weekly research updates, please contact cpicb.randdoffice.nhs.net.

You can also now follow the R&D team on Twitter/ X.